These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37834229)

  • 1. Systemic Effects of Homoarginine Supplementation on Arginine Metabolizing Enzymes in Rats with Heart Failure with Preserved Ejection Fraction.
    Büttner P; Werner S; Böttner J; Ossmann S; Schwedhelm E; Thiele H
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction.
    Büttner P; Adams V; Werner S; Ossmann S; Besler C; Schwedhelm E; Thiele H
    ESC Heart Fail; 2022 Dec; 9(6):4348-4351. PubMed ID: 36043453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine metabolism and nitric oxide turnover in the ZSF1 animal model for heart failure with preserved ejection fraction.
    Büttner P; Werner S; Baskal S; Tsikas D; Adams V; Lurz P; Besler C; Knauth S; Bahls M; Schwedhelm E; Thiele H
    Sci Rep; 2021 Oct; 11(1):20684. PubMed ID: 34667218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of urinary amino acids and their post-translational modifications (PTM) including advanced glycation end-products (AGEs) of lysine, arginine and cysteine in lean and obese ZSF1 rats.
    Baskal S; Büttner P; Werner S; Besler C; Lurz P; Thiele H; Tsikas D
    Amino Acids; 2022 Apr; 54(4):643-652. PubMed ID: 34250558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal injury in relation to obesity and the additive effect of hypertension in female and male obese and lean ZSF1 rats.
    Nguyen ITN; Cramer MJ; Joles JA; Verhaar MC
    Am J Physiol Renal Physiol; 2023 Jul; 325(1):F73-F86. PubMed ID: 37227224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction.
    Leite S; Moreira-Costa L; Cerqueira R; Sousa-Mendes C; Angélico-Gonçalves A; Fontoura D; Vasques-Nóvoa F; Leite-Moreira AF; Lourenço AP
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):690-701. PubMed ID: 34328815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and distribution of pharmacological homoarginine in plasma and main organs of the anesthetized rat.
    Günes DN; Kayacelebi AA; Hanff E; Lundgren J; Redfors B; Tsikas D
    Amino Acids; 2017 Dec; 49(12):2033-2044. PubMed ID: 28710553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model.
    Hamdani N; Franssen C; Lourenço A; Falcão-Pires I; Fontoura D; Leite S; Plettig L; López B; Ottenheijm CA; Becher PM; González A; Tschöpe C; Díez J; Linke WA; Leite-Moreira AF; Paulus WJ
    Circ Heart Fail; 2013 Nov; 6(6):1239-49. PubMed ID: 24014826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction.
    Schauer A; Draskowski R; Jannasch A; Kirchhoff V; Goto K; Männel A; Barthel P; Augstein A; Winzer E; Tugtekin M; Labeit S; Linke A; Adams V
    ESC Heart Fail; 2020 Oct; 7(5):2123-2134. PubMed ID: 32710530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence by GC-MS that lysine is an arginase-catalyzed metabolite of homoarginine in vitro and in vivo in humans.
    Bollenbach A; Cordts K; Hanff E; Atzler D; Choe CU; Schwedhelm E; Tsikas D
    Anal Biochem; 2019 Jul; 577():59-66. PubMed ID: 31028716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction.
    Leite S; Cerqueira RJ; Ibarrola J; Fontoura D; Fernández-Celis A; Zannad F; Falcão-Pires I; Paulus WJ; Leite-Moreira AF; Rossignol P; López-Andrés N; Lourenço AP
    Circ Heart Fail; 2019 Jul; 12(7):e005596. PubMed ID: 31525070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Davila A; Tian Y; Czikora I; Li J; Su H; Huo Y; Patel V; Robinson V; Kapuku G; Weintraub N; Bagi Z
    Circ Heart Fail; 2019 Aug; 12(8):e005762. PubMed ID: 31525084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
    Nguyen ITN; Brandt MM; van de Wouw J; van Drie RWA; Wesseling M; Cramer MJ; de Jager SCA; Merkus D; Duncker DJ; Cheng C; Joles JA; Verhaar MC
    PLoS One; 2020; 15(5):e0232399. PubMed ID: 32374790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
    Moreira-Costa L; Tavares-Silva M; Almeida-Coelho J; Gonçalves A; Trindade F; Vasques-Nóvoa F; Sousa-Mendes C; Leite S; Vitorino R; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
    Eur J Pharmacol; 2024 Mar; 966():176336. PubMed ID: 38272343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot Study on Acute Effects of Pharmacological Intraperitoneal L-Homoarginine on Homeostasis of Lysine and Other Amino Acids in a Rat Model of Isoprenaline-Induced Takotsubo Cardiomyopathy.
    Tsikas D; Redfors B
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and haemodynamic characterization of right ventricle in sedentary and trained rats with heart failure with preserved ejection fraction.
    Oliveira MI; Leite S; Barros A; Lourenço AP; Mendes C; Schmidt C; Santos M; Leite-Moreira A; Moreira-Gonçalves D
    Exp Physiol; 2021 Dec; 106(12):2457-2471. PubMed ID: 34676608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscular changes in animal models of heart failure with preserved ejection fraction: what comes closest to the patient?
    Goto K; Schauer A; Augstein A; Methawasin M; Granzier H; Halle M; Craenenbroeck EMV; Rolim N; Gielen S; Pieske B; Winzer EB; Linke A; Adams V
    ESC Heart Fail; 2021 Feb; 8(1):139-150. PubMed ID: 33350094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
    Stolina M; Luo X; Dwyer D; Han CY; Chen R; Zhang Y; Xiong Y; Chen Y; Yin J; Shkumatov A; Ason B; Hale C; Véniant MM
    PLoS One; 2020; 15(8):e0231234. PubMed ID: 32804947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction.
    Miranda-Silva D; Wüst RCI; Conceição G; Gonçalves-Rodrigues P; Gonçalves N; Gonçalves A; Kuster DWD; Leite-Moreira AF; van der Velden J; de Sousa Beleza JM; Magalhães J; Stienen GJM; Falcão-Pires I
    Acta Physiol (Oxf); 2020 Mar; 228(3):e13378. PubMed ID: 31520455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.